Capricor Therapeutics, Inc. (CAPR)
NASDAQ: CAPR · Real-Time Price · USD
9.53
-0.71 (-6.93%)
At close: Nov 13, 2026, 4:00 PM EST
9.36
-0.17 (-1.78%)
After-hours: Nov 13, 2026, 7:32 PM EST

Capricor Therapeutics Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
231
Market Cap
554.09M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025---
Dec 31, 202422.27M-2.91M-11.55%
Dec 31, 202325.18M22.63M886.81%
Dec 31, 20222.55M2.31M941.85%
Dec 31, 2021244.90K-65.35K-21.06%
Dec 31, 2020310.25K-694.78K-69.13%
Dec 31, 20191.01M-666.33K-39.87%
Dec 31, 20181.67M-994.98K-37.32%
Dec 31, 20172.67M-1.33M-33.32%
Dec 31, 20164.00M-1.52M-27.53%
Dec 31, 20155.52M730.95K15.27%
Dec 31, 20144.79M4.28M851.19%
Dec 31, 2013503.23K--
Dec 31, 2012---
Dec 31, 20111.35M--
Dec 31, 2010---
Dec 31, 2009---
Dec 31, 2008---
Dec 31, 2007---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Valneva SE163.30M
REGENXBIO153.91M
Zevra Therapeutics147.76M
Orchestra BioMed Holdings31.21M
Crescent Biopharma15.00M
Surrozen10.53M
Neurogene925.00K
Entera Bio42.00K
Revenue Rankings